Self-reactive thymocytes are eliminated by negative selection, whereas competent thymocytes survive by positive selection. The strength of the T-cell receptor (TCR) signal determines the fate of thymocytes undergoing either positive or negative selection. The TCR signal strength is relatively higher in negative selection than in positive selection and induces pro-apoptotic molecules such as Nur77 and Nor-1, which are members of the orphan nuclear receptor family, that then cause TCR-mediated apoptosis. However, at the molecular level, it remains unclear how positive or negative selection is distinguished based on the TCR signal. We found that the expression of Twist2 is differentially regulated in positively and negatively selected thymocytes. In particular, TCR signal strength that elicits positive selection induces Twist2 expression via the Ca 2+ -Cacineurin-NFATc3 pathway, whereas strength of the TCR signal that results in negative selection abolishes NFATc3-dependent Twist2 induction via specific activation of the JNK pathway. Using Twist2-deficient and Twist2 transgenic mice, we also found that Twist2 determines thymocyte sensitivity to TCR-mediated apoptosis by regulating the expression of Nur77 and Nor-1. Twist2 partially retains histone deacetylase 7 (HDAC7) in the nucleus and recruits it to the Nur77 promoter region to repress Nur77 in positively selected thymocytes. Thus our results suggest a molecular mechanism of how thymocytes interpret the strength of the TCR signal and how TCR sensitivity is controlled during thymic selection.
T-cells develop from bone marrow-derived progenitors entering the thymus. Initially, immature thymocytes generate and present T-cell receptors (TCRs) on their surface, which recognize the peptide-loaded major histocompatibility complexes (pMHCs) presented by thymic antigen-presenting cells. In order for TCRs to gain infinite reactivity to continually changing pathogens, β and α chains of the TCR are sequentially generated through random rearrangement of somatic V(D)J gene segments. Even though this random recombination process confers a great diversity onto the repertoire of TCRs, it also generates unwanted TCRs that are either unreactive or overtly reactive to self-peptide-loaded MHCs (self-pMHCs).
Following the production of surface TCRs, thymic selection eliminates the useless and self-reactive clones while allowing the survival of competent thymocytes. Thymocyte fate is determined by the affinity of their TCRs for self-pMHCs and the resulting strength of delivered signals. Notably, when thymocytes relay TCR signals that are too strong in terms of a high affinity toward self-pMHCs, they induce apoptotic genes, such as Nur77 and Nor-1, and die by 'negative selection'. Only thymocytes possessing TCRs with moderate affinity toward self-pMHCs survive by 'positive selection' and are allowed to differentiate further.
The interaction between a TCR and a self-pMHC in thymocytes activates Ras/mitogen-activated protein kinases, such as ERK and JNK, and the Ca 2+ -Calcineurin-NFATc3 pathway through a phosphorylation cascade of kinases downstream of TCR. [1] [2] [3] [4] [5] It has been shown that ERK and Calcineurin are activated by the strength of TCR signaling that results in positive selection, whereas JNK activation is triggered only when negative selection strength of TCR signaling is perceived. 6 Correspondingly, genetic studies in mouse models demonstrate that the ERK and CalcineurinNFATc3 pathways promote positive selection, 5, [7] [8] [9] [10] whereas the JNK pathway supports negative selection of thymocytes. 11, 12 However, the downstream events that connect these signaling pathways to their target thymocyte fate are currently not well understood.
During negative selection, Nur77 and Nor-1, which are members of the Nr4a receptor family, are rapidly induced by a strong TCR signal and cause thymocyte apoptosis. [13] [14] [15] Massive cell death of thymocytes is observed in both Nur77 and Nor-1 transgenic mice. 13, 16, 17 However, Nur77 null mice do not show any abnormalities in negative selection. 18 By contrast, negative selection is impaired in mice expressing a dominant-negative form of the Nur77 protein. 19 It was revealed that these discrepancies are due to the functional redundancy between Nur77 and Nor-1. 17, 19 Therefore, simultaneous control of Nur77 and Nor-1 is indispensable for the regulation of negative selection. The histone deacetylase 7 (HDAC7) has been reported to repress Nur77 expression. 20 In TCRinexperienced double-positive (DP) thymocytes, nuclear HDAC7 represses Nur77 transcription by interacting with MEF2D, a transcription factor constitutively bound to the MEF2 site in the Nur77 promoter. However, in thymocytes receiving TCR signaling, HDAC7 is released from the Nur77 promoter and exported to the cytoplasm. [20] [21] [22] Subsequently, the empty MEF2 site in the Nur77 promoter is rapidly occupied by p300 and other transcription co-activators that initiate Nur77 expression. [23] [24] [25] Nevertheless, a recent study showed that HDAC7 is exported to the cytoplasm even during positive selection. 26 Thus the nuclear/cytoplasmic shuttling of HDAC7 alone is not sufficient to explain the differential expression levels of Nur77 depending on the selected cell fate and suggests involvement of an additional regulator(s).
In this study, we show that Twist2 is induced in thymocytes upon TCR stimulation through the Ca 2+ -Calcineurin-NFATc3 pathway. Conversely, specific activation of JNK during negative selection interferes NFATc3-dependent Twist2 induction. TCR-mediated apoptosis of thymocytes is augmented in the absence of Twist2, whereas enforced expression of Twist2 prevents thymocyte apoptosis. Twist2 partially retains HDAC7 in the nucleus of positively selected thymocytes and represses Nur77 expression by facilitating HDAC7 binding to the Nur77 promoter. Thus we demonstrate that Twist2 determines TCR sensitivity in the developing thymocytes.
Results
Expression of Twist2 is upregulated by TCR signaling in developing thymocytes. Depending on the expression pattern of TCRβ and CD69, the developmental stages of thymocytes can be divided into three regions: R1 (Region 1), R2 (Region 2), and R3 (Region 3) (Supplementary Figure S1a) ). In particular, DP cells in the R1 population are TCR-inexperienced pre-selected DP (pre-DP) cells, whereas DP cells in the R2 population are TCRexperienced post-selected DP (post-DP) cells. Twist2 expression was relatively high at the DN stage and decreased at the pre-DP stage (Figure 1a, Supplementary Figures S1b  and c) . However, it resurged at the post-DP stage and persisted throughout later developmental stages (Figure 1a , Supplementary Figures S1b and c) . The induction of Twist2 at the post-DP stage was upregulated at the transcriptional level (Figure 1b) .
Expression of Twist2 is induced by the Ca

2+
-CalcineurinNFATc3 pathway. To examine whether Twist2 expression is directly regulated by TCR signaling, Twist2 promoter region was cloned and transfected into 16610D9 cells, which are a DP thymoma cell line. 27 TCR signaling was mimicked by treating with phorbol-12-myristate-13-acetate (PMA) and ionomycin (IM). The promoter activity of Twist2 was efficiently induced by treatment with 0.1 ng/ml PMA and 200 ng/ml IM (P0.1/I200) or with 10 ng/ml PMA and 500 ng/ml IM (P10/I500) (Figure 1c) . Interestingly, the treatment with IM alone (I200 or I500) successfully induced Twist2 promoter activity (Supplementary Figure S2a) . IM activates Ca 2+ signaling and its downstream components, including Calcineurin and NFAT. Interrupting the Ca 2+ signaling by pretreating with Cyclosporin A (CsA), an inhibitor of Calcineurin, completely abolished Twist2 promoter activity after both P0.1/I200 and P10/I500 stimulation (Figure 1c ). In addition, the expression of Twist2 was induced in neither thymocytes isolated from the Calcineurin B1 knockout (CnB1 − / − ) nor the NFATc1/NFATc3 double conditional knockout (cKO) (NFATc1, c3 − / − ) mice after stimulation with P0.1/I200 condition ( Figure 1d ).
The proximal 177 bp of the Twist2 promoter region was sufficient for mediating the PMA/IM response and three putative NFAT-binding sites were detected in this sequence ( Supplementary Figures S2b and c) . Given that NFATc3 is dominantly expressed among NFAT families at the pre-DP stage, 9, 28 we named these sites c3-1, c3-2, and c3-3, respectively. NFATc3 bound to the c3-1 and c3-3 sites but not to the c3-2 site (Figure 1e ). When combinational mutations in the NFAT-binding sites were introduced into the Twist2 promoter, the promoter activity was dependent on the presence of the c3-1 and c3-3 sites but not of the c3-2 site (Figure 1f) . When both the c3-1 and c3-3 sites were mutated, NFATc3-dependent augmentation of the Twist2 promoter activity was completely abolished (Figure 1f ). In conclusion, TCR signaling induces Twist2 expression via the transcriptional activity of NFATc3.
NFATc3-dependent Twist2 expression is repressed by JNK activity. P0.1/I200 and P10/I500 conditions are experimentally determined to mimic positive and negative selection, respectively. 29, 30 Interestingly, Twist2 promoter activity was lowered in P10/I500 condition ( Figure 1c) . We thus assumed that Twist2 is differentially regulated during positive and negative selection. To test this possibility, OVA 323-339 peptide (OVAp) was injected to the Rag − / − × DO11.10-TCR-Tg (hereafter, DO-TCR-Tg) mice to transduce negative selection strength TCR signal. Consistently, Twist2 expression was downregulated by injection with OVAp ( Figure 2a ). Next we analyzed the temporal kinetics of Twist2 expression depending on the strength of the TCR signal. Unlike the sustained upregulation of Twist2 until 6 h under the P0.1/I200 condition, the Twist2 expression was terminated by 3 h upon P10/I500 stimulation and remained low thereafter (Figure 2b ). Thus these data suggest that Twist2 expression is repressed by the negative selection strength TCR signal.
NFATc3 localized to the cytoplasm in unstimulated 16610D9 cells (non) and entered the nucleus upon IM stimulation (I200) (Figure 2c) . Conversely, the majority of NFATc3 was observed Twist2 regulates TCR-mediated thymocyte apoptosis S Oh et al in the cytoplasm upon IM and PMA co-treatment (P10/I200) ( Figure 2c ). To verify whether JNK, which is activated by the PMA treatment, exports nuclear NFATc3 to the cytoplasm, cells were pretreated with the JNK inhibitor SP600125 prior to P10/I200 stimulation. When JNK signaling was specifically inhibited, NFATc3 was localized to the nucleus despite PMA presence (Figure 2c) . Consequently, the binding of NFATc3 to the Twist2 promoter was decreased upon P10/I500 stimulation compared with P0.1/I200 stimulation (Figure 2d ). Thus these results indicate that specific activation of JNK during negative selection interferes NFATc3-dependent Twist2 expression. ). Gating strategy is described in Supplementary Figure S1a . Mean fluorescence intensity (MFI) of Twist2 is normalized to IgG, and the results are presented relative to DN stage (error bars ± S.E.M., n = 9). (b) Twist2 expression in sorted pre-DP and post-DP cells was measured by quantitative PCR (qPCR). The expression of Twist2 is normalized to β-actin expression, and the results are presented relative to pre-DP stage (error bars, ± S.E.M., n = 5). (c) 1 kb Twist2 promoter was transfected to 16610D9 cells, and the luciferase activities were measured after treatment with combinations with PMA (P0.1, 0.1 ng/ml; and P10, 10 ng/ml) and/or IM (I200, 200 ng/ml; and I500, 500 ng/ml). For those indicated below the graph, 5 μg/ml of CsA were treated 15 min before PMA and IM treatment. The graph presents the relative percentage of luciferase activities to P0.1/I200-treated cells (error bars, ± S.E.M., n = 3). (d) Twist2 expression in thymocytes from Lck-Cre, CnB1
, and NFATc1, c3 − / − mice was measured by qPCR after stimulation with P0.1/I200 for 3 h or not (non). Twist2 expression is normalized to β-actin expression, and the results are presented relative to not treated (non) thymocytes from Lck-Cre mice (error bars, ± S.E.M., n = 3). (e) Nuclear extracts from 16610D9 cells were prepared 3 h after P0.1/I200 stimulation. Electrophoretic mobility shift assay was performed on the three putative NFAT-binding sites with the nuclear extracts. Before gel running, anti-NFATc3 antibody was incubated (+) or not (− ). (f) 177 bp or NFAT-binding site mutants of Twist2 promoter constructs were co-transfected with a mock vector (mock) or a NFATc3 expression vector (NFATc3) in 16610D9 cells. After 36 h, cells were further activated with I200 for 6 h, and the luciferase activities were measured (error bars, ± S.E.M., n = 3)
Twist2 regulates TCR-mediated thymocyte apoptosis S Oh et al TCR-experienced thymocytes are decreased in Twist2-deficient mice. To define the role of Twist2 in thymocyte development, Twist2 f/f mice were crossed with Cd4-Cre mice. The expression of Twist2 was decreased in thymocytes obtained from Twist2 f/f × Cd4-Cre (cKO) mice compared with that in Twist2 +/+ × Cd4-Cre (control) mice at both the RNA and the protein level ( Supplementary Figures S3a-c) . We first noticed that the thymic cellularity was slightly reduced in cKO mice compared with control mice (Figure 3a) . When we analyzed which developmental stages are reduced in cKO mice, both the percentage and the cell number of the R3 population were decreased in cKO mice compared with control mice (Figures 3b and c) . To validate whether these differences are due to a defect in cell-intrinsic role of Twist2, we conducted mixed bone marrow transfer experiments. Consistently, the percentage of the R3 population was reduced in CD45.2 cKO thymocytes compared with CD45.1 control thymocytes (Supplementary Figures S4a and b) .
Interestingly, the percentage of R2 population in CD45.2 cKO thymocytes was significantly reduced compared with CD45.1 control thymocytes (Supplementary Figure S4b) . Among the R2 population, the percentage of semimature SP cells, but not post-DP cells, was decreased in both cKO mice and CD45.2 cKO thymocytes (Supplementary Figures S4c and S5a), implying that the significance of Twist2 deletion occurred at the semimature SP stage and enhanced in the competitive environment.
Loss of Twist2 increases the TCR sensitivity to thymocyte apoptosis. Developing thymocytes are more sensitive to TCR stimulation than mature T cells. 31 When apoptotic cells were detected in thymocytes, the percentage of AnnexinV + cells was significantly increased in the R3 population of cKO mice compared with those in control mice (Figure 4a) . Intriguingly, the percentage of apoptotic cells in the R2 population was also increased in cKO mice ( Figure 4a ). However, the significance was comparable in the post-DP population between cKO and control mice (Supplementary Figure S5b) , implying that the increased percentage of apoptosis in the R2 population occurs at the semimature SP stage. To substantiate whether Twist2 regulates the TCR-mediated apoptosis of thymocytes, thymocytes from control and cKO mice with the DO-TCR-Tg background were co-cultured with MHC-matching (H-2A d ) B cells after pulsing with OVAp. In this system, DO-TCR + DP thymocytes undergo apoptosis after recognizing OVAp. 32 DP cell viability was gradually decreased depending on the dose of OVAp, and it was more significant in cKO mice than that in control mice (Figure 4b) . Further, to test directly whether the sensitivity to TCR-induced apoptosis increases in the absence of Twist2, thymocyte apoptosis was measured after treatment with PMA and IM (PMA/IM). TCR-experienced thymocytes were precluded by crossing to the Tcrα − / − mice. In cKO thymocytes, PMA/IM-induced apoptosis, but not spontaneous apoptosis, was significantly increased (Figure 4c ).
Twist2 inhibits TCR-mediated apoptosis and negative selection of thymocytes. In contrast to the cKO mice, PMA/IM-induced apoptosis of thymocytes was inhibited in Twist2-Tg mice (Figure 5a ). We assumed that the discontinued expression of Twist2 is pivotal for the clonal deletion during negative selection. To test this hypothesis, we employed the OT2-TCR-Tg and Rip-mOVA-Tg (hereafter, mOVA-Tg) mouse system and crossed with Twist2-Tg mice. In this system, ovalbumin is expressed in the thymic medulla 
lo Vα2 hi population (Figures 5b-d) . 33 Unlike the dramatic reduction of both total thymic cellularity and the percentage of the CD24 lo Vα2 hi population in non-transgenic littermate control (NLC) mice, negative selection was impaired in Twist2-Tg mice (Figures 5b-d) .
Notably, thymic cellularity in OT2-TCR × Twist2-Tg mice was decreased compared with OT2-TCR-Tg mice (Figure 5c ). The reduced thymic cellularity in Twist2-Tg mice might be influenced by a yet unexplored role of Twist2 at the DN stage as inferred from the increased DN population in OT2-TCR × Twist2-Tg mice (Figure 5b) . As only the CD4 SP cells in the CD24 lo Vα2 hi population are eliminated by negative selection in OT2-TCR × mOVA-Tg mouse system, we calculated the fold reduction of CD4 SP cells to measure the efficiency of negative selection specifically. As expected, the efficiency of negative selection in CD4 SP cells was lower in Twist2-Tg mice than that in NLC mice (NLC: 73.88 ± 5.218% versus Twist2-Tg: 49.78 ± 4.681%) (Supplementary Figure S6) .
Twist2 regulates the expression of Nur77 and Nor-1. Nur77 is required for the negative selection in OT2-TCR × mOVA-Tg mice system. 33, 34 To determine whether Twist2 regulates Nur77 induction in this system, we measured Nur77 levels in the CD24 lo Vα2 hi CD4 + population (Figure 6a ). In OT2-TCR × mOVA-Tg mice, both the percentage of Nur77 hi cells and the expression of Nur77 were significantly increased compared with OT2-TCR-Tg mice (Figures 6a-c) . However, Nur77 induction was attenuated in the presence of Twist2-Tg strain (Figures 6a-c) . To assess whether Twist2 regulates Nur77 expression at the transcriptional level, the expression of Nur77 and its related gene, Nor-1, was measured in thymocytes obtained from NLC and Twist2-Tg mice after PMA/IM treatment. Consistently, the induction of Nur77 and Nor-1 was repressed in Twist2-Tg mice (Figure 6d) . Conversely, the expression of Nur77 and Nor-1 was significantly increased in cKO mice compared with control mice (Figure 6e ). Twist2 regulates TCR-mediated thymocyte apoptosis S Oh et al
To examine whether Twist2 directly regulates the expression of Nur77 and Nor-1, the promoter region of Nur77 and Nor-1 was cloned and the promoter activities were detected in 16610D9 cells after PMA/IM stimulation (Figure 6f ). Twist2 repressed the promoter activities of Nur77 and Nor-1 (Figures 6g and h) . The MEF2D-binding site (MEF2 site) and the HDAC7-binding site (HDAC7 site) have been reported in each promoter region. 15, 23, 35 Twist2 bound to the MEF2 site in the Nur77 promoter and the HDAC7 site in the Nor-1 promoter (Figure 6i ). To validate whether Twist2 regulates the activities of Nur77 and Nor-1 promoters at these sites, we prepared mutant promoter constructs (Nur77-mutMEF2 and Nor-1-mutHDAC7). Unlike intact Nur77 and Nor-1 constructs, Twist2 failed to repress the mutant promoters (Figures 6g and h ).
Twist2 interacts with MEF2D and HDAC7 to repress the expression of Nur77 and Nor-1. Next we tested whether Twist2 physically associates with MEF2D and HDAC7. To detect protein-protein interaction, we conducted a bimolecular fluorescence complementation (BiFC) analysis. 36 In this system, if two proteins interact, the combined VN/VC (VENUS) emits green fluorescence. It was previously reported that MEF2C, which shares a highly conserved sequence with MEF2D, interacts with full-length Twist2, but not with a C-terminal-deleted form of Twist2 (Twist2CΔ). 37 Consistently, full-length Twist2, but not Twist2CΔ, interacted with MEF2D (Figure 7a ). HDAC7 was also associated with full-length Twist2, but not with Twist2CΔ, in both BiFC and co-immunoprecipitation analysis (Figure 7a and Supplementary Figure S7) .
As Twist2 interacted with MEF2D and HDAC7, we deduced that Twist2 enhances the binding of HDAC7 to the Nur77 promoter. Twist2 recruited HDAC7 to the Nur77 promoter regardless of PMA/IM stimulation, whereas it prevented the binding of p300 (Figures 7b and c and Supplementary Figure S8a) . Although HDAC7 is mainly detected in the cytoplasm of positively selected thymocytes, 26 nuclear HDAC7 in DP thymocytes was higher in OT2-TCR × Twist2-Tg mice than that in OT2-TCR-Tg mice (Figure 7d ). In addition, Twist2 inhibited the nuclear export of HDAC7 in 16610D9 cells upon TCR stimulation (Supplementary Figure S8b) . To delineate whether Twist2 represses the Nur77 expression through the physical interactions with MEF2D and HDAC7, the promoter activity of Nur77 was measured in the presence of Twist2CΔ. In contrast to full-length Twist2, Twist2CΔ was neither able to repress the Nur77 promoter activity nor induce apoptosis in 16610D9 cells upon PMA/IM stimulation (Figures 7e and f) .
Discussion
In this study, we show that Twist2 is differentially regulated depending on the strength of TCR signaling and determines TCR sensitivity of developing thymocytes. At the downstream of proximal TCR signaling, Twist2 expression is upregulated by the Ca 2+ -Calcineurin-NFATc3 pathway in positively selected thymocytes, whereas it is repressed by the JNK pathway, which is Twist2 regulates TCR-mediated thymocyte apoptosis S Oh et al specifically activated in negatively selected thymocytes. In addition, TCR sensitivity of thymocytes is determined depending on the expression level of Twist2. Hence, it seems that Twist2 determines the fate of thymocyte, either positive or negative, selection at the downstream of TCR signaling. It is known that the Ca 2+ -Calcineurin signal is preferentially required for positive selection and that the activated Calcineurin dephosphorylates NFATc3 to allow its translocation into the nucleus. 5 On the contrary, it has also been reported that activation of the JNK pathway inhibits transcriptional activity of NFATc3 by exporting NFATc3 to the cytoplasm. 38 However, the physiological significance of JNK-mediated export of NFATc3 has not been elucidated. We found that Twist2 expression was reciprocally regulated by NFATc3 and JNK. Under the strength of TCR stimulation that induces positive selection, NFATc3 bound to the Twist2 promoter and activated the promoter activity. By contrast, activated JNK pathway upon negative selection strength of TCR stimulation interfered with the NFATc3-mediated Twist2 expression. Thus here we suggest a model whereby thymocytes translate the strength of TCR signaling into Twist2 expression.
Based on the low expression of Nur77 in positively selected thymocytes, it is expected that localization of HDAC7 would be nuclear in these cells. However, HDAC7 in mainly detected in the cytoplasm of positively selected thymocytes. 26 Interestingly, however, Twist2 partially sequestered HDAC7 in the nucleus of activated 16610D9 cells and positively selected DP thymocytes. Moreover, Twist2 could recruit HDAC7 to the Nur77 promoter. The remaining question is how Twist2 recruits HDAC7 to the Nur77 promoter. Our current work suggests that Twist2 can physically interact with both MEF2D and HDAC7. Subsequently, Twist2 recruits HDAC7 on the Nur77 promoter while preventing the binding of p300 to the same site. Thus it seems that Twist2 modulates the binding abilities of transcriptional activators and repressors on the Nur77 promoter depending on the strength of the TCR signal.
Another interesting finding is that Twist2 can simultaneously regulate the expression of Nur77 and Nor-1. It has been reported that Nor-1 has a functional redundancy with Nur77 during negative selection of thymocytes. [17] [18] [19] HDAC7 mutant mice (HDAC7ΔP-Tg), where HDAC7 lost its nuclear export property, show decreased expression of Nur77 and Nor-1.
34
These results imply a possible role for HDAC7 in the The expression of Nur77 and Nor-1 was detected using qPCR in thymocytes from NLC and Twist2-Tg mice (d) or control and cKO mice (e) after stimulation with PMA and IM (PMA/IM). All mice were crossed with Tcrα − / − mice to preclude TCR-experienced thymocytes. The expression of Nur77 and Nor-1 expression is normalized to β-actin expression, and the results are presented relative to non-stimulated respective control thymocytes (error bars, ± S.E.M.). (f) Schematic diagrams of the Nur77 and the Nor-1 promoter constructs used in luciferase assay. Mutated sequences in each promoter are indicated in red color. (g and h) Twist2 expression vector was co-transfected into 16610D9 cells with Nur77 and Nur77-mutMEF2 promoter constructs (g) or Nor-1 and Nor-1-mutHDAC7 promoter constructs (h). Luciferase activities were detected after the PMA/IM treatment. The results are presented relative to the promoter activity in mock-transfected cells (error bars, ± S.E.M.). (i) ChIP assay was performed in thymocytes from DO-TCR × Twist2-Tg mice. The binding of Twist2 to the promoters of Nur77 and Nor-1 was detected by semi-qPCR. The band intensity was quantified using the ImageJ software (National Institutes of Health, Bethesda, MD, USA) and normalized to Input (error bars, ± S.E.M.)
Twist2 regulates TCR-mediated thymocyte apoptosis S Oh et al expression of Nor-1 as well as Nur77. Unlike the Nur77 promoter where MEF2D has a role as an anchor protein for HDAC7, no MEF2D-binding elements have been reported in the Nor-1 promoter region. It is yet unclear whether Twist2 represses Nor-1 expression in a MEF2D-dependent manner. Nevertheless, we found that Twist2 bound to the same region of Nor-1 promoter as HDAC7 and that Twist2 promoted the HDAC7 binding to the Nor-1 promoter. Therefore, a Twist2/ HDAC7 complex is crucial for the simultaneous regulation of Nur77 and Nor-1 expression.
It was previously reported that the secretion of TNFα is increased in Twist2-null mice and Twist2 − / − cells are sensitive to TNFα-induced apoptosis. 39 As TNFα is constitutively expressed in the thymus, 40 it is possible that the elevated apoptosis of thymocytes in the cKO mice is also due to their increased sensitivity to TNFα-induced apoptosis. However, TNFα-induced apoptosis is mostly restricted to the DN stage cells and negative selection does not appear to be affected by TNFα. 41, 42 In addition, Twist2 was deleted in DP cells after the DN stage in the cKO mice. Twist2 may also have a role in thymocyte development together with E-proteins, as it forms a heterodimer with E-proteins via the bHLH domain. 37, 43 Downregulation of E-protein activity during DP-to-SP transition is crucial for thymic selection because mice with mutated Id3, another E-protein-binding partner that lacks a DNAbinding domain, displayed abnormalities in positive and negative selection. 44 Thus it is conceivable that abnormal E-protein activity in cKO mice may increase thymocyte apoptosis even in the presence of functional Id3. However, Twist2CΔ protein, which still has the ability to form a heterodimer with E-proteins, failed to repress TCR-mediated apoptosis. Of note, it has also been reported that Twist2 functions as a repressor by interacting with transcription factors other than E-proteins. 39, 45 Therefore, even though there is a possibility of a partial contribution of Twist2/E-protein heterodimers to thymic selection, it is more likely that the increased apoptosis during thymic selection in cKO mice is due to enhanced TCR sensitivity caused by the disruption of the Twist2/HDAC7 complex on the promoters of Nur77 and Nor-1, which is independent from E-protein activity.
Nur77 was reported to be expressed in positively selected thymocytes, although its expression level is one-fifth in induction-fold compared with that of negatively selected cells. 46, 47 However, it was also reported that positive selection was normal in the Nur77-deficient mice. 18, 48 Recently, enhanced positive selection was reported in Nur77 and Bim double knockout mice. 48 It seems that the veiled function of Nur77 in positive selection was revealed only when Nur77 was disrupted simultaneously with Bim. We have shown that Twist2 represses the expression of Nur77. However, Twist2 does not appear to regulate the Bim expression (data not shown). Therefore, our results that no significant change in positive selection occurred in Twist2-Tg mice seem to be consistent with the previous results that Nur77 deficiency alone has a minimal effect in positive selection. Nur77 and Nor-1 have a crucial role in thymocyte apoptosis upon TCR signaling. Consequently, the abnormal regulation of Nur77 and Nor-1 expression leads to impaired thymocyte development, which ultimately results in an unhealthy immune system. Despite the importance of Nur77 and Nor-1, the transcription factor(s) that is differentially regulated by TCR signaling and regulates Nur77 and Nor-1 expression has not been identified yet. Our study provides evidences that Twist2 is discriminatively regulated depending on the intensity of the TCR signal and determines the expression level of Nur77 and Nor-1 in cooperation with HDAC7. Thus Twist2 appears to be a pivotal regulator of survival and death in developing thymocytes.
Materials and Methods
Mice. A cDNA encoding mouse Twist2 was obtained by reverse transcription-PCR (RT-PCR) from thymocyte RNA preparations and was cloned into the BamHI site of the p1017 vector under the control of a mouse Lck proximal promoter by using conventional cloning procedures. 49 Twist2 transgenic mice were obtained essentially as described previously. 50 To specifically delete Twist2 in thymocytes, Twist2 f/f mice were crossed with Cd4-Cre-Tg mice. Tcrα
, OT2-TCR-Tg, and Rip-mOVA-Tg mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA). Rag − / − × DO11.10 TCR-Tg mice were purchased from Taconic Farms (Germantown, NY, USA). The mice were bred and maintained under specific pathogen-free condition, and experiments were performed in accordance with institutional and national guidelines.
Flow cytometric analysis and cell sorting. Thymocytes were harvested, stained, and analyzed on a FACSCanto II (BD Biosciences, San Jose, CA, USA). Antibodies with the following specificities were used for staining: anti-CD69-PerCP, anti-Vα2-biotin, anti-TCRβ-APC, anti-CD4-PE, anti-CD4-PEcy7, anti-CD8α-APCcy7, anti-CD24-PE-cy7, anti-CD24-FITC, anti-DO11.10-TCR-PerCP, and anti-Streptavidin-APC (all from BD Biosciences or eBioscience (San Diego, CA, USA)). Where indicated, thymocytes were sorted into TCRβ + (post-DP) subpopulations on a FACSAria II (BD Biosciences). The purity of all sorted population was 495%.
DP cell viability assay, AnnexinV staining, and intracellular staining. Untouched B cells were sorted using Dynabeads (Invitrogen, Carlsbad, CA, USA) following the manufacturer's instruction. Briefly, splenocytes of BALB/c mice were mixed with Dynabeads and biotin-conjugated anti-CD4, anti-CD8, antiTer119, anti-CD3ε, anti-CD11b, and anti-GR1 antibodies for 20 min at RT. Supernatants containing bead-free untouched B cells were separated using magnet and collected into a new tube. DP cell viability was detected by gating DO11.10 TCR + CD4 + CD8 + population after incubation for 24 h with untouched B cells. OVA 323-339 (ISQAVHAAHAEINEAGR) peptide (GL Biochem, Shanghai, China) was preloaded before 30 min to untouched B cells prior to the incubation with thymocytes. For AnnexinV staining, thymocytes and 16610D9 cells were activated with PMA (LC laboratories, Woburn, MA, USA) and IM (LC Laboratories), and apoptosis was detected using the AnnexinV-FITC Apoptosis Kit (BD Biosciences) according to the manufacturer's protocol. For intracellular staining, fleshly isolated thymocytes were stained with anti-CD4-PEcy7, anti-CD8-APCcy7, anti-TCRβ-APC, anti-CD69-PerCP, anti-CD24-FITC, anti-Vα2-Biotin, and anti-Streptavidin-APC antibodies. Stained thymocytes were fixed and further stained with anti-IgG, antiTwist2, or anti-Nur77-PE antibodies using the Foxp3 Fix/Perm Kit (eBioscience) following the manufacturer's instruction. To detect intracellular Twist2, anti-IgG-PE antibody was further added.
Cell culture and luciferase assay. Primary thymocytes were cultured on RPMI medium with 10% FBS and 2-mercaptoethanol. 16610D9 cells were maintained with Opti-MEM (Invitrogen, Carlsbad, CA, USA) supplemented with 10% FBS and 2-mercaptoethanol. For luciferase assay, the promoters of Nur77 and Nor-1 and the Twist2 promoter were obtained from genomic DNA of Jurkat T cell line and c57BL/6 mouse, respectively, and cloned into pGL3-basic vector. Point mutations in each promoter constructs were generated by site-directed mutagenesis as instructed (Stratagene, La Jolla, CA, USA). 51 Designated vectors in each experiment were transfected in 16610D9 cells. Twenty four-hours later, cells were treated with PMA/IM and luciferase activities were detected using the Luciferase Assay Kit (Promega, Madison, WI, USA) as instructed in manual. CsA (Sigma, St. Louis, MO, USA) was treated 15 min before the treatment of PMA and IM.
